跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,591 条关于
“WEE1/PKMYT1”
全部
1,591
临床试验
1,382
药物
15
机构
0
资讯
194
去年
Acrivon Therapeutics Initiates Phase 1 Trial of WEE1/PKMYT1 Inhibitor ACR-2316 for Solid Tumors
5个月前
Debiopharm Reports First Clinical Data from MYTHIC Trial Combining WEE1 and PKMYT1 Inhibitors at AACR 2026
去年
Acrivon Therapeutics to Showcase AP3 Platform and Clinical Program Updates at Upcoming R&D Event
7个月前
Acrivon Therapeutics Launches CLIA-Certified Laboratory to Advance Precision Medicine Development
去年
FDA Grants Breakthrough Device Status to Acrivon's AI-Powered Cancer Diagnostic Platform
去年
Acrivon Therapeutics Appoints Renowned Oncologist Dr. Mansoor Raza Mirza as Chief Medical Officer to Lead Clinical Development
去年
Acrivon Therapeutics Grants Equity Awards to Employees Under Nasdaq Rule 5635(c)(4)
2年前
Acrivon's ACR-368 Shows Promise in Endometrial Cancer, ACR-2316 Advances to Clinic
3个月前
Acrivon Therapeutics Reports 44% Response Rate for CHK1/2 Inhibitor ACR-368 in Endometrial Cancer Phase II Trial
2年前
Repare Therapeutics Advances Oncology Pipeline with Multiple Clinical Trials
第 1 页,共 20 页
上一页
下一页